Squarepoint’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$373K Buy
+64,705
New +$373K ﹤0.01% 2057
2025
Q1
Sell
-91,680
Closed -$799K 3024
2024
Q4
$799K Buy
+91,680
New +$799K ﹤0.01% 1668
2024
Q3
Sell
-16,319
Closed -$336K 2792
2024
Q2
$336K Sell
16,319
-78,969
-83% -$1.63M ﹤0.01% 1908
2024
Q1
$2.03M Buy
95,288
+129
+0.1% +$2.75K ﹤0.01% 1027
2023
Q4
$1.37M Buy
95,159
+17,928
+23% +$258K ﹤0.01% 1204
2023
Q3
$704K Buy
77,231
+34,592
+81% +$315K ﹤0.01% 1464
2023
Q2
$451K Buy
42,639
+25,615
+150% +$271K ﹤0.01% 1641
2023
Q1
$208K Sell
17,024
-39,101
-70% -$478K ﹤0.01% 1855
2022
Q4
$697K Sell
56,125
-21,274
-27% -$264K ﹤0.01% 1292
2022
Q3
$1.06M Buy
77,399
+43,582
+129% +$595K 0.01% 1052
2022
Q2
$620K Buy
+33,817
New +$620K ﹤0.01% 1275
2022
Q1
Sell
-40,119
Closed -$562K 2559
2021
Q4
$562K Buy
+40,119
New +$562K ﹤0.01% 1529
2021
Q3
Sell
-39,310
Closed -$820K 2512
2021
Q2
$820K Sell
39,310
-6,119
-13% -$128K ﹤0.01% 1313
2021
Q1
$1.28M Buy
45,429
+9,794
+27% +$277K 0.01% 932
2020
Q4
$1.16M Buy
35,635
+13,343
+60% +$436K 0.01% 985
2020
Q3
$683K Sell
22,292
-30,731
-58% -$942K 0.01% 1141
2020
Q2
$864K Sell
53,023
-38,568
-42% -$628K 0.01% 1017
2020
Q1
$911K Sell
91,591
-37,646
-29% -$374K 0.02% 751
2019
Q4
$1.78M Buy
129,237
+46,878
+57% +$645K 0.01% 957
2019
Q3
$1.25M Buy
82,359
+57,615
+233% +$874K 0.01% 1053
2019
Q2
$487K Buy
24,744
+14,248
+136% +$280K ﹤0.01% 1647
2019
Q1
$174K Sell
10,496
-44,300
-81% -$734K ﹤0.01% 1913
2018
Q4
$769K Sell
54,796
-9,124
-14% -$128K 0.01% 1023
2018
Q3
$1.12M Buy
63,920
+29,520
+86% +$517K 0.01% 937
2018
Q2
$626K Buy
34,400
+16,723
+95% +$304K 0.01% 1087
2018
Q1
$331K Buy
17,677
+6,199
+54% +$116K 0.01% 1269
2017
Q4
$176K Buy
+11,478
New +$176K ﹤0.01% 1822
2017
Q2
Sell
-22,318
Closed -$196K 1675
2017
Q1
$196K Buy
22,318
+9,800
+78% +$86.1K 0.01% 1282
2016
Q4
$74K Buy
+12,518
New +$74K ﹤0.01% 1666